Back to search

Premax Europe Limited

10333816

active
ltd
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

29-30 Elvaston Mews, London, SW7 5HZ
Incorporated 17/08/2016

Compliance

Last accounts

31/08/2025

unaudited abridged

Next accounts due

31/05/2027

On track

Confirmation statement

Last: 16/08/2025

Due 30/08/2026

On track

Industry

21100
Manufacture of basic pharmaceutical products
46460
Wholesale of pharmaceutical goods
47910
Retail sale via mail order houses or via Internet

Officers

Peter Damian Brukner

director · Since 17/08/2016

Australian · Australia · Age 73

Randall Lyall Cooper

director · Since 17/08/2016

Australian · Australia · Age 51

Cameron John Tudor

director · Since 17/08/2016

British · England · Age 51

Persons with Significant Control

Mr Peter Damian Brucker

25–50% shares
ownership-of-shares-25-to-50-percent-as-trust
ownership-of-shares-75-to-100-percent-as-firm
25–50% votes
voting-rights-25-to-50-percent-as-trust
voting-rights-75-to-100-percent-as-firm
right-to-appoint-and-remove-directors-as-firm

Australian · Australia · Age 73

29-30, Elvaston Mews, London, SW7 5HZ

Notified 17/08/2016

Mr Randall Lyall Cooper

50–75% shares
ownership-of-shares-50-to-75-percent-as-trust
ownership-of-shares-75-to-100-percent-as-firm
50–75% votes
voting-rights-50-to-75-percent-as-trust
voting-rights-75-to-100-percent-as-firm
Appoint directors
right-to-appoint-and-remove-directors-as-trust
right-to-appoint-and-remove-directors-as-firm

Australian · Australia · Age 51

29-30, Elvaston Mews, London, SW7 5HZ

Notified 17/08/2016

Change History

status → active
2026-06-09

Active

type → ltd
2026-06-09

Private Limited Company

address line1 → 29-30 Elvaston Mews
2026-06-09

29-30 ELVASTON MEWS

post town → London
2026-06-09

LONDON

officer appointed → BRUKNER, Peter Damian
2026-06-09
officer appointed → COOPER, Randall Lyall
2026-06-09
officer appointed → TUDOR, Cameron John
2026-06-09

CompanyRankvs 660+ SIC 21100 peers
38

Financial strength11th percentile among SIC peers · 3/25
Employees27th percentile among SIC peers · 4/15
LiquidityCurrent ratio 0.69× · 6/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Lofthouse Of Fleetwood Limited
90
2West Pharmaceutical Services Cornwall Limited
90
3Dr. Reddy'S Laboratories (Eu) Limited
90
4Mw Encap Limited
90
5Rsr Limited
90
6Aura-Soma Products Limited
89
7Tcs Biosciences Limited
89
8Pharmapac (U.K.) Limited
89
9Onyx Scientific Limited
89
10International Scientific Supplies Limited
89
660Premax Europe Limited
33
How is this score calculated?
Financial strength3/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees4/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/08/2025

Net Worth

-£34k

Balance sheet strength

Cash

£20k

Cash in the bank

Net Current Assets

-£35k

Working capital

Current Assets

£79k

Current Liabilities

£114k

Fixed Assets

£628

Debtors

£14k

0avg. employees

Balance Sheet

Assets less current liabilities-£34k
Signed by 2024-09-01Prepared with Companies House

EstimatesDerived

YearCurrent RatioImplied Profit
20250.69+£0
20250.69+£20k
20240.69-£148k
20230.34+£218k
20220.14-£46k
20210.35-£68k
20200.82—
20191.02—
20180.97—

Derived from filed accounts. Not audited figures.